MarketScreener Strategies Astellas Pharma Inc. OTC Markets

Stocks

Market Closed - OTC Markets 15:59:54 2026-09-28 EDT			5-day change	1st Jan Change
14.95 ^USD	-1.77%		-1.71%	+12.49%

09-23	Astellas Pharma Inc. Doses First Patient In Phase 3 Study Of Setidegrasib In Previously Treated KRAS G12D-Mutated Advanced Non-Small Cell Lung Cancer	CI
09-16	Astellas Pharma Inc. Announces Executive Changes	CI

August 27, 2026 at 04:09 am

No results match your criteria

Astellas' Profits May Have Doubled, But Can It Outrun the Street's Skepticism?

August 27, 2026 at 04:09 am

Astellas CEO on Outlook Ahead of Trump's Pharma Tariffs